PE20090624A1 - Diaminopirimidinas - Google Patents

Diaminopirimidinas

Info

Publication number
PE20090624A1
PE20090624A1 PE2008000379A PE2008000379A PE20090624A1 PE 20090624 A1 PE20090624 A1 PE 20090624A1 PE 2008000379 A PE2008000379 A PE 2008000379A PE 2008000379 A PE2008000379 A PE 2008000379A PE 20090624 A1 PE20090624 A1 PE 20090624A1
Authority
PE
Peru
Prior art keywords
pyrimidin
amino
compounds
metoxy
alcoxy
Prior art date
Application number
PE2008000379A
Other languages
English (en)
Inventor
Michael Patrick Dillon
Daisy Joe Du Bois
Alam Jahangir
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PE20090624A1 publication Critical patent/PE20090624A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Abstract

SE REFIERE A COMPUESTOS DERIVADOS DE DIAMINOPIRIMIDINAS DE FORMULA (I) DONDE R1 ES ALCOXI(C1-C6), HIDROXI O HALOGENO; R2 ES ALCOXI(C1-C6), HALOGENO, ALQUILSULFONILO(C1-C6) O AMINOSULFONILO. SON COMPUESTOS PREFERIDOS: 2-[4-AMINO-5-(5-YODO-2-ISOPROPIL-4-METOXI-FENOXI)-PIRIMIDIN-2-ILAMINO]-PROPANO-1,3-DIOL, 5-[4-AMINO-2-(2-HIDROXI-1-HIDROXIMETIL-ETILAMINO)-PIRIMIDIN-5-ILOXI]-4-ISOPROPIL-2-METOXI-BENCENOSULFONAMIDA, 2-[4-AMINO-5-(4-CLORO-5-YODO-2-ISOPROPIL-FENOXI)-PIRIMIDIN-2-ILAMINO]-PROPANO-1,3-DIOL, ENTRE OTROS. SE REFIERE TAMBIEN A UN PROCESO DE PREPARACION Y A UNA COMPOSICION FARMACEUTICA. DICHOS COMPUESTOS SON MODULADORES DE LOS RECEPTORES PURINERGICOS P2X SIENDO UTILES EN EL TRATAMIENTO DE INCONTINENCIA, HIPERTROFIA BENIGNA DE PROSTATA, VEJIGA HIPERACTIVA, CISTITIS, NEURALGIAS
PE2008000379A 2007-02-28 2008-02-25 Diaminopirimidinas PE20090624A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US90407907P 2007-02-28 2007-02-28

Publications (1)

Publication Number Publication Date
PE20090624A1 true PE20090624A1 (es) 2009-05-16

Family

ID=39297415

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2008000379A PE20090624A1 (es) 2007-02-28 2008-02-25 Diaminopirimidinas

Country Status (6)

Country Link
US (1) US20080207655A1 (es)
AR (1) AR065477A1 (es)
CL (1) CL2008000554A1 (es)
PE (1) PE20090624A1 (es)
TW (1) TW200845995A (es)
WO (1) WO2008104474A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2009003257A (es) * 2006-10-04 2009-04-07 Hoffmann La Roche Procedimiento para la sintesis de derivados de fenoxi diaminopirimidina.
WO2013184827A1 (en) 2012-06-05 2013-12-12 Pastine Stefan J Synthesis of and compositions containing diaminoacetals and diaminoketals
MY195728A (en) * 2013-08-23 2023-02-07 Afferent Pharmaceuticals Inc Diaminopyrimidine P2x3 and P2x 2/3 Receptor Modulators for Treatment of Acute, Sub-Acute or Chronic Cough
HRP20230445T1 (hr) * 2015-09-29 2023-07-21 Afferent Pharmaceuticals Inc. Modulatori diaminopirimidin p2x3 i p2x2/3 receptora za primjenu u liječenju kašlja
WO2017160569A1 (en) 2016-03-14 2017-09-21 Afferent Pharmaceuticals Inc. Pyrimidines and variants thereof, and uses therefor
BR112018069105A2 (pt) 2016-03-25 2019-01-29 Afferent Pharmaceuticals Inc pirimidinas e variantes das mesmas, e usos para tais
US10676444B2 (en) * 2016-12-20 2020-06-09 Afferent Pharmaceuticals, Inc. Crystalline salts and polymorphs of a P2X3 antagonist
US10919839B2 (en) 2017-07-11 2021-02-16 Aditya Birla Chemicals (Usa) Llc Silicon-containing compositions and their methods of use
SG11202111960PA (en) * 2019-04-30 2021-12-30 Beijing Tide Pharmaceutical Co Ltd Method for treating endometriosis-associated pain by using diaminopyrimidine compound

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1930135B (zh) * 2004-03-05 2011-12-28 弗·哈夫曼-拉罗切有限公司 作为p2x3和p2x2/3拮抗剂的二氨基嘧啶
BRPI0615040A2 (pt) * 2005-09-01 2011-04-26 Hoffmann La Roche diaminopirimidinas como moduladores de p2x3 e p2x2/3
EP1924566B1 (en) * 2005-09-01 2016-01-13 F.Hoffmann-La Roche Ag Diaminopyrimidines as p2x3 and p2x2/3 modulators
JP4850911B2 (ja) * 2005-09-01 2012-01-11 エフ．ホフマン−ラ ロシュ アーゲー Ｐ２ｘ３およびｐ２ｘ２／３モジュレーターとしてのジアミノピリミジン

Also Published As

Publication number Publication date
US20080207655A1 (en) 2008-08-28
CL2008000554A1 (es) 2008-08-29
TW200845995A (en) 2008-12-01
AR065477A1 (es) 2009-06-10
WO2008104474A1 (en) 2008-09-04

Similar Documents

Publication Publication Date Title
PE20090624A1 (es) Diaminopirimidinas
PE20070427A1 (es) Compuestos derivados de benzimidazoles sustituidos como inhibidores de tirosina quinasas
EA200800726A1 (ru) Введение ингибиторов дипептидилпептидазы
PE20060530A1 (es) Aril y heteroaril derivados sustituidos como moduladores del metabolismo de la glucosa
UY32409A (es) Compuesto de anillo fusionado y su uso
NO20081034L (no) Pyrimidinforbindelser som serotoninreseptormodulatorer
PE20120602A1 (es) ATROPISOMEROS DE 2-[(6-AMINO-9H-PURIN-9-IL)METIL]-5-METIL-3-o-TOLILQUINAZOLIN-4(3H)-ONA
ECSP088221A (es) Agonistas adrenoreceptores alfa2c
EA200970088A1 (ru) Модуляторы метаболизма и лечение связанных с ним нарушений
PE20120002A1 (es) Derivados de benceno sustituido con glucopiranosilo como inhibidores de sglt2
PE20140245A1 (es) Compuesto de furo[3,2-d]pirimidina
BRPI0911035A2 (pt) ativadores de pirrolidinona glicoquinase
PE20080948A1 (es) Derivados de imidazol como moduladores de la senda de hedgehog
GT200800158A (es) Pirazolquinolonas como potentes inhibidores de parp
EA200970519A1 (ru) Полиморфы сукцината 2-[6-(3-аминопиперидин-1-ил)-3-метил-2,4-диоксо-3,4-дигидро-2h-пиримидин-1-илметил]-4-фторбензонитрил и способы их применения
PE20070517A1 (es) Derivados de imidazol como agentes inhibidores de la sintasa de aldosterona y aromatasa
EA201170151A1 (ru) Пиперидиниловые агонисты gpcr
PE20060857A1 (es) Derivados de piridinilo y pirimidinilo sustituidos como moduladores del metabolismo y para tratar trastornos metabolicos
GT200600038A (es) Agonistas de pyy y sus usos
PA8658301A1 (es) Derivados fusionados de pirazol y metodos de tratamiento de trastornos metabolicos con estos
CL2007002492A1 (es) Compuestos derivados de bi-,tri o policiclos no aromaticos, inhibidores de la enzima 11-beta-hidroxiesteroide deshidrogenasa tipo i; proceso de preparacion de estos; composicion famaceutica que los comprende; uso en el tratamiento de enfermedades tales como la obesidad, diabetes y dislipidemia, entre otras.
EA201100503A1 (ru) Глюкозидные производные и их применения
CR10243A (es) "bencimidazoles 2-sustituidos como modulares de receptor de androgeno selectivos"
PE20081700A1 (es) Derivados de acido de piranona sustituidos como agentes para tratar el sindrome metabolico
CL2008002826A1 (es) Compuestos derivados de pirimidina alquiltio sustituidas, antagonista crth2; composicion farmaceutica que comprende a dicho compuestos; y uso para tratar una enfermedad alergica, asma, dermatitis atopica, psoriasis, colitis ulcerantes, sinusitis, leucemia basofilica, entre otras.

Legal Events

Date Code Title Description
FC Refusal